Cargando…
OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis
BACKGROUND: A recently developed global indicator of oxidative stress (OXY-SCORE), by combining individual plasma biomarkers of oxidative damage and antioxidant capacity, has been validated in several pathologies, but not in left ventricular hypertrophy (LVH). The aim of this study was to design and...
Autores principales: | Quintana-Villamandos, Begoña, Pazó-Sayós, Laia, González del Pozo, Irene, Rodríguez-Rodríguez, Pilar, Bellón, Jose María, Pedraz-Prieto, Álvaro, Pinto, Ángel G, González, Maria Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328060/ https://www.ncbi.nlm.nih.gov/pubmed/32647560 http://dx.doi.org/10.1177/2040622320936417 |
Ejemplares similares
-
Plasma protein thiolation index (PTI) as a potential biomarker for left ventricular hypertrophy in humans
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2019) -
Inhibition of the NFATc4/ERK/AKT Pathway and Improvement of Thiol-Specific Oxidative Stress by Dronedarone Possibly Secondary to the Reduction of Blood Pressure in an Animal Model of Ventricular Hypertrophy
por: Pazó-Sayós, Laia, et al.
Publicado: (2020) -
Maintenance over Time of the Effect Produced by Esmolol on the Structure and Function of Coronary Arteries in Hypertensive Heart Diseases
por: Martín-Oropesa, Raquel, et al.
Publicado: (2022) -
Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2018) -
Left Ventricular Hypertrophy in Patients with X-Linked Hypophosphataemia
por: Castellano-Martinez, Ana, et al.
Publicado: (2022)